kabutan

SAPPORO CLINICAL LAB, Last Fiscal Year Ordinary Profit Revised Upward to an Unexpected 38% Increase

Wed May 7, 2025 3:30 pm JST Revision

9776 SAPPORO CLINICAL LABORATORY INC. 【J-GAAP】

Guidance Update Report

SAPPORO CLINICAL LABORATORY INC. <9776> [TSE Std] announced a performance revision after the market closed on May 7th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 has been revised upward 43.4%, from the previous forecast of 493 million yen to 707 million yen (compared to 514 million yen in the previous period), turning to a 37.5% increase in the consolidated ordinary profit outlook.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated ordinary profit is expected to increase 2.4 times, from the previous forecast of 150 million yen to 364 million yen (compared to 218 million yen in the same period of the previous year), turning to a 67.0% increase in the consolidated ordinary profit outlook.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev 9,803 163 150 98 31.4 23 Nov 1, 2024 J-GAAP
Oct - Mar, 2024 New 10,135 369 364 242 77.4 23 May 7, 2025 J-GAAP
Revision Rate +3.4% +126.4% +142.7% +146.9% +146.3%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 19,799 500 493 320 102.6 23 May 13, 2024 J-GAAP
Mar, 2025 New 20,131 706 707 464 148.4 23 May 7, 2025 J-GAAP
Revision Rate +1.7% +41.2% +43.4% +45.0% +44.6%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 9,820 243 218 154 46.3 23 May 13, 2024 J-GAAP
Oct - Mar, 2024 Guidance 10,135 369 364 242 77.4 23 May 7, 2025 J-GAAP
YoY +3.2% +51.9% +67.0% +57.1% +67.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 20,127 1,008 1,159 568 170.5 23 May 12, 2023 J-GAAP
Mar, 2024 19,682 534 514 380 114.1 23 May 13, 2024 J-GAAP
Mar, 2025 Guidance 20,131 706 707 464 148.4 23 May 7, 2025 J-GAAP
YoY +2.3% +32.2% +37.5% +22.1% +30.0%

Related Articles